Mast Therapeutics (NYSE:MSTX) CEO Interview


Mast Therapeutics
CEO: Brian Culley



This interview includes forward-looking statements, within the meaning of federal securities laws, about Mast Therapeutics’ business prospects, financial position, and pharmaceutical development programs.  Any statement that is not a statement of historical fact should be considered a forward-looking statement.  Because forward-looking statements relate to the future, they are only predictions that reflect the Company’s beliefs based on current information and speak only as of the date on which they are made. Accordingly, you are cautioned not to place undue reliance on forward-looking statements. For a description of risks and uncertainties that could cause material differences between the Company’s actual results and those stated or implied by the forward-looking statements, please see the Company’s press releases and filings with the Securities and Exchange Commission, including its annual report on Form 10-K filed on March 24, 2015.  These filings are available on the Company’s website,, and at  


About author

This article was written by The Wall Street Analyzer

The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum. On one hand our financial experience gives us the ability to identify promising, off the grid companies before they are uncovered by the rest of the market, and on the other hand our media experience allows us to produce interviews which appeal to a large audience because we provide a format in which more investors can understand a featured companies' upside. Our philosophy is to turn stock tickers into stories, ideas into headlines, and technical and financial data into easy to understand tidbits, easier to digest and therefore consumed by a larger audience. These interviews provide a jumping off point for investors to do further research into a prospective company. Our editorials seek to provide an out-of-the-box perspective found in few other financial sites.